Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.95 is 81% below its 5-year average of 5.13, near the low end of its 5-year range (0.82–11.29).
As of the fiscal period ended Tuesday, June 30, 2026. 75.88% below its 12-month average of 3.95.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.95.
QUICK RATIO (ACID-TEST)
0.95
QUICK RATIO (ACID-TEST) AVG TTM
3.95
QUICK RATIO (ACID-TEST) AVG 3Y
4.40
QUICK RATIO (ACID-TEST) AVG 5Y
5.13
QUICK RATIO (ACID-TEST) AVG 10Y
5.41
QUICK RATIO (ACID-TEST) AVG 15Y
4.53
QUICK RATIO (ACID-TEST) AVG 20Y
4.37
CURRENT VS TTM AVG
-75.88%
CURRENT VS 3Y AVG
-78.34%
CURRENT VS 5Y AVG
-81.44%
CURRENT VS 10Y AVG
-82.40%
CURRENT VS 15Y AVG
-78.97%
CURRENT VS 20Y AVG
-78.22%
SECTOR MEDIAN · HEALTHCARE
3.28
median of 795 covered companies
CURRENT VS SECTOR MEDIAN
-70.96%
vs the sector median at left
Achieve Life Sciences, Inc.
Market Cap
$730.28M
Quick Ratio (Acid-Test)
0.95
TTM Avg
3.95
3Y Avg
4.40
5Y Avg
5.13
Market Cap
$736.18M
Quick Ratio (Acid-Test)
16.09
TTM Avg
8.04
3Y Avg
7.87
5Y Avg
9.13
Market Cap
$738.30M
Quick Ratio (Acid-Test)
19.69
TTM Avg
6.38
3Y Avg
9.16
5Y Avg
11.87
Market Cap
$727.50M
Quick Ratio (Acid-Test)
14.16
TTM Avg
12.98
3Y Avg
15.39
5Y Avg
17.04
Market Cap
$718.68M
Quick Ratio (Acid-Test)
3.86
TTM Avg
4.81
3Y Avg
5.95
5Y Avg
7.14
Market Cap
$714.67M
Quick Ratio (Acid-Test)
0.84
TTM Avg
1.18
3Y Avg
1.08
5Y Avg
1.08
Market Cap
$752.29M
Quick Ratio (Acid-Test)
18.86
TTM Avg
23.23
3Y Avg
26.78
5Y Avg
32.61
Market Cap
$706.51M
Quick Ratio (Acid-Test)
8.86
TTM Avg
10.22
3Y Avg
11.35
5Y Avg
25.38
Market Cap
$701.75M
Quick Ratio (Acid-Test)
19.31
TTM Avg
14.05
3Y Avg
7.67
5Y Avg
5.91
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Achieve Life Sciences, Inc. (ACHV) | $730.28M | 0.95 | 3.95 | 4.40 | 5.13 |
| Candel Therapeutics, Inc. (CADL)vs › | $736.18M | 16.09 | 8.04 | 7.87 | 9.13 |
| Faeth Therapeutics, Inc. (FTH)vs › | $738.30M | 19.69 | 6.38 | 9.16 | 11.87 |
| ArriVent BioPharma, Inc. (AVBP)vs › | $727.50M | 14.16 | 12.98 | 15.39 | 17.04 |
| Cytek Biosciences, Inc. (CTKB)vs › | $718.68M | 3.86 | 4.81 | 5.95 | 7.14 |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $714.67M | 0.84 | 1.18 | 1.08 | 1.08 |
| Design Therapeutics, Inc. (DSGN)vs › | $752.29M | 18.86 | 23.23 | 26.78 | 32.61 |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $706.51M | 8.86 | 10.22 | 11.35 | 25.38 |
| Avalo Therapeutics, Inc. (AVTX)vs › | $701.75M | 19.31 | 14.05 | 7.67 | 5.91 |
| Mesa Laboratories, Inc. (MLAB)vs › | $763.75M | 1.52 | 0.88 | 1.36 | 2.75 |
Quick Ratio
0.95
Excludes inventory
Current Ratio
0.95
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.95 |
| 2026-03-31 | 2.62 |
| 2025-12-31 | 4.39 |
| 2025-09-30 | 5.14 |
| 2025-06-30 | 6.64 |
| 2025-03-31 | 3.51 |
| 2024-12-31 | 5.46 |
| 2024-09-30 | 6.78 |
| 2024-06-30 | 4.56 |
| 2024-03-31 | 3.29 |
| 2023-12-31 | 0.82 |
| 2023-09-30 | 5.36 |
| 2023-06-30 | 7.65 |
| 2023-03-31 | 0.90 |
| 2022-12-31 | 1.27 |
| 2022-09-30 | 3.03 |
| 2022-06-30 | 5.81 |
| 2022-03-31 | 9.40 |
| 2021-12-31 | 9.80 |
| 2021-09-30 | 11.29 |
| 2021-06-30 | 9.09 |
| 2021-03-31 | 8.66 |
| 2020-12-31 | 12.60 |
| 2020-09-30 | 13.02 |
| 2020-06-30 | 6.99 |
| 2020-03-31 | 8.36 |
| 2019-12-31 | 6.04 |
| 2019-09-30 | 2.43 |
| 2019-06-30 | 3.62 |
| 2019-03-31 | 2.63 |
| 2018-12-31 | 4.77 |
| 2018-09-30 | 4.56 |
| 2018-06-30 | 5.64 |
| 2018-03-31 | 2.05 |
| 2017-12-31 | 2.82 |
| 2017-09-30 | 3.70 |
| 2017-06-30 | 8.25 |
| 2017-03-31 | 8.81 |
| 2016-12-31 | 3.22 |
| 2016-09-30 | 3.08 |
| 2016-06-30 | 2.89 |
| 2016-03-31 | 3.19 |
| 2015-12-31 | 2.79 |
| 2015-09-30 | 2.30 |
| 2015-06-30 | 1.73 |
| 2015-03-31 | 2.62 |
| 2014-12-31 | 2.49 |
| 2014-09-30 | 2.93 |
| 2014-06-30 | 2.37 |
| 2014-03-31 | 2.85 |
| 2013-12-31 | 3.61 |
| 2013-09-30 | 4.16 |
| 2013-06-30 | 5.32 |
| 2013-03-31 | 6.81 |
| 2012-12-31 | 6.94 |
| 2012-09-30 | 4.42 |
| 2012-06-30 | 3.83 |
| 2012-03-31 | 3.70 |
| 2011-12-31 | 2.19 |
| 2011-09-30 | 3.87 |
| 2011-06-30 | 2.83 |
| 2011-03-31 | 3.28 |
| 2010-12-31 | 3.25 |
| 2010-09-30 | 3.50 |
| 2010-06-30 | 3.91 |
| 2010-03-31 | 3.08 |
| 2009-12-31 | 2.65 |
| 2009-09-30 | 5.74 |
| 2009-06-30 | 3.05 |
| 2009-03-31 | 7.11 |
| 2008-12-31 | 4.94 |
| 2008-09-30 | 5.30 |
| 2008-06-30 | 11.10 |
| 2008-03-31 | 6.68 |
| 2007-12-31 | 5.53 |
| 2007-09-30 | 2.48 |
| 2007-06-30 | 3.49 |
| 2007-03-31 | 3.77 |
| 2006-12-31 | 3.36 |
| 2006-09-30 | 4.45 |
| 2006-06-30 | 5.31 |
| 2006-03-31 | 4.17 |
| 2005-12-31 | 5.05 |
| 2005-09-30 | 4.27 |
| 2005-06-30 | 5.06 |
| 2005-03-31 | 6.76 |
| 2004-12-31 | 6.46 |
| 2004-09-30 | 10.69 |
| 2004-06-30 | 11.53 |
| 2004-03-31 | 8.93 |
| 2003-12-31 | 9.75 |
| 2003-09-30 | 8.64 |
| 2003-06-30 | 4.84 |
| 2003-03-31 | 7.43 |
| 2002-12-31 | 8.58 |
| 2002-09-30 | 7.76 |
